Bronchodilator Responsiveness Positivity More Likely in Morning
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 12, 2025 -- Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March 11 in Thorax.
Ben Knox-Brown, Ph.D., from the Royal Papworth Hospital NHS Foundation Trust in Cambridge, England, and colleagues examined the association between time of day and season of testing on the level of bronchodilator responsiveness in a population of 1,620 patients.
The researchers found that the odds of a positive bronchodilator response decreased by 8 percent per one-hour increment in the working day (odds ratio, 0.92). When time of day was dichotomized into morning and afternoon periods, a similar effect was seen, with reduced odds of responsiveness in the afternoon (odds ratio, 0.68). The impact of time of day was only seen in those referred for asthma/query asthma, while no association was seen for those referred for other reasons. Compared with the rest of the year, bronchodilator responsiveness was more common in winter months.
"These findings suggest that performing diagnostic testing when patients are most symptomatic, that is, in the morning, may improve diagnostic testing," the authors write. "This also reinforces the need to document the timing of spirometry testing whenever possible, and that repeat testing should be done at the same time of day."
One author disclosed financial ties to ndd Medical Technologies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-13 06:00
Read more

- Black Patients With Cancer Still Have Higher Mortality Rates Than Whites
- AAOS: Header Ban Linked to Decrease in Soccer-Linked Concussions in Children
- ASA: Alteplase Ups Outcomes at 4.5 to 24 Hours After Symptom Onset in Acute Ischemic Stroke
- Gynecological Disorders Can Increase Risk for Cardiovascular, Cerebrovascular Disease
- Phase III Study Shows Xolair May Be More Effective With Fewer Side Effects Than Oral Immunotherapy for the Treatment of Food Allergies
- U.S. Facing Critical Hospital Bed Shortage
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions